149 Recruiting Sickle Cell Disease Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Sickle Cell Disease Studies
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
📍 Methodist Comprehensive Sickle Cell Center — Memphis, Tennessee
View Study & Checklist ➔Kidney Function in Sickle Cell Anemia
📍 University of North Carolina-Chapel Hill — Chapel Hill, North Carolina
View Study & Checklist ➔BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Virtual Reality for SCD VOC
📍 University of Maryland Medical Center, Stoler Infusion Center — Baltimore, Maryland
View Study & Checklist ➔Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Acupressure in Patients With Sickle Cell Disease
📍 University of California, Irvine — Irvine, California
View Study & Checklist ➔Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor
📍 Alberta Children's Hospital — Calgary, Alberta
View Study & Checklist ➔Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
📍 Grady Health System — Atlanta, Georgia
View Study & Checklist ➔A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
📍 Uni of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
📍 Children's National Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔A Study of Intravenous L-Citrulline in Patients Aged 6-21 Years Old With Sickle Cell Disease Presenting to Emergency Departments in Acute Vaso-Occlusive Crisis
📍 Children's National Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔Long-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)
📍 University of Chicago — Chicago, Illinois
View Study & Checklist ➔Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)
📍 Levine Children's Hospital - Hematology — Charlotte, North Carolina
View Study & Checklist ➔Functional Ovarian Reserve in Sickle Cell Disease
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
View Study & Checklist ➔Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0
📍 University of Cincinnati College of Medicine — Cincinnati, Ohio
View Study & Checklist ➔Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease
📍 University of California Los Angeles (UCLA) — Los Angeles, California
View Study & Checklist ➔Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
📍 Children's National Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔Stress Management and Mindfulness Intervention for Patients With Sickle Cell Disease
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)
📍 UCSF Benioff Children's Hospital — Oakland, California
View Study & Checklist ➔Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
📍 University Hospitals Case Medical Center — Cleveland, Ohio
View Study & Checklist ➔Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
📍 University of Illinois at Chicago — Chicago, Illinois
View Study & Checklist ➔Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in Treatment Decision Making (EMPOWER-AYA)
📍 Nemours Children's Hospital, Delaware — Wilmington, Delaware
View Study & Checklist ➔Glucose Metabolism in Sickle Cell Disease
📍 University of Illinois at Chicago — Chicago, Illinois
View Study & Checklist ➔Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease
📍 Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
View Study & Checklist ➔Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Integrative Training Program for Pediatric Sickle Cell Pain
📍 Connecticut Children's Medical Center — Hartford, Connecticut
View Study & Checklist ➔Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
📍 UCSF Benioff Children's Hospital Oakland — Oakland, California
View Study & Checklist ➔Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
📍 University Of Alabama — Birmingham, Alabama
View Study & Checklist ➔Cerebral Oxygen Metabolism in Children
📍 Washington University of St. Louis — St Louis, Missouri
View Study & Checklist ➔A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
📍 University of Alabama Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)
📍 UConn Health — Farmington, Connecticut
View Study & Checklist ➔Development and Evaluation of an Information Management System and Communication System for Population-wide Point-of-care Infant Sickle Cell Disease Screening
📍 Baylor College of Medicine — Houston, Texas
View Study & Checklist ➔TMLI and Alemtuzumab for Treatment of Sickle Cell Disease
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)
📍 University of California San Diego — La Jolla, California
View Study & Checklist ➔Sickle Cell Clinical Research and Intervention Program
📍 Children's Hospital of Illinois at OSF-Saint Francis Medical Center — Peoria, Illinois
View Study & Checklist ➔Cannabidiol in Sickle Cell Disease
📍 Icahn School of Medicine at Mount Sinai — Manhattan, New York
View Study & Checklist ➔Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies
📍 Boston Children's Hospital — Boston, Massachusetts
View Study & Checklist ➔